ofloxacin has been researched along with Endomyometritis in 7 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Endomyometritis: Inflammation of both the ENDOMETRIUM and the MYOMETRIUM, usually caused by infections after a CESAREAN SECTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy and safety of levofloxacin (LVFX) 500mg qd were evaluated in female patients with cervicitis with Chlamydia trachomatis and intrauterine infections." | 9.15 | [Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis]. ( Ando, Y; Fujiwara, M; Hoshina, S; Izumi, K; Kinoshita, C; Kurashima, M; Mikamo, H; Nakabe, K; Takahashi, K; Yamagishi, Y; Yoshimura, M; Yoshioka, M, 2011) |
| "The clinical efficacy and safety of levofloxacin (LVFX) 500mg qd were evaluated in female patients with cervicitis with Chlamydia trachomatis and intrauterine infections." | 5.15 | [Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis]. ( Ando, Y; Fujiwara, M; Hoshina, S; Izumi, K; Kinoshita, C; Kurashima, M; Mikamo, H; Nakabe, K; Takahashi, K; Yamagishi, Y; Yoshimura, M; Yoshioka, M, 2011) |
| " Two hundred thirty-one patients developed postpartum endometritis, and the isolates obtained from the endometrium were tested for sensitivity to ampicillin, cefuroxime, ofloxacin, ciprofloxacin, and clindamycin." | 5.07 | Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis. ( Faro, S; Hammill, HA; Maccato, M; Martens, MG; Riddle, G, 1991) |
| "30." | 2.68 | [Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections]. ( Badonnel, Y; Dailloux, M; Judlin, P; Koebele, A; Landes, P; Pavis, A; van Walleghen, E; Zaccabri, A, 1995) |
| "Ofloxacin was used in the complex therapy of acute inflammatory diseases of the uterus and uterine appendages." | 2.68 | [Comparative evaluation of the effectiveness of ofloxacin in comprehensive treatment of acute inflammatory diseases of the uterus and uterine appendages]. ( Denisova, EN; Evseev, AA; Savel'eva, GM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikamo, H | 2 |
| Yamagishi, Y | 1 |
| Takahashi, K | 1 |
| Izumi, K | 2 |
| Hoshina, S | 1 |
| Nakabe, K | 1 |
| Fujiwara, M | 1 |
| Yoshimura, M | 1 |
| Ando, Y | 1 |
| Kurashima, M | 1 |
| Kinoshita, C | 1 |
| Yoshioka, M | 1 |
| Judlin, P | 1 |
| Koebele, A | 1 |
| Zaccabri, A | 1 |
| van Walleghen, E | 1 |
| Pavis, A | 1 |
| Badonnel, Y | 1 |
| Dailloux, M | 1 |
| Landes, P | 1 |
| Verhoest, P | 1 |
| Fernandez, H | 1 |
| Henry-Suchet, J | 1 |
| Orfila, J | 1 |
| Boulanger, JC | 1 |
| Savel'eva, GM | 1 |
| Evseev, AA | 1 |
| Denisova, EN | 1 |
| Kawazoe, K | 1 |
| Sato, Y | 1 |
| Tamaya, T | 1 |
| Chimura, T | 1 |
| Morisaki, N | 1 |
| Funayama, T | 1 |
| Oda, T | 1 |
| Martens, MG | 1 |
| Faro, S | 1 |
| Maccato, M | 1 |
| Riddle, G | 1 |
| Hammill, HA | 1 |
5 trials available for ofloxacin and Endomyometritis
| Article | Year |
|---|---|
[Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis].
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Dru | 2011 |
[Comparative study of ofloxacin+amoxicillin-clavulanic acid versus doxycycline+amoxicillin-clavulanic acid combination in the treatment of pelvic Chlamydia trachomatis infections].
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Chlamydia Infections; | 1995 |
[A new therapeutic strategy using a ofloxacin-amoxicillin-clavulanic acid combination in the treatment of upper gynecologic infections. Apropos of 123 cases].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibito | 1994 |
[Comparative evaluation of the effectiveness of ofloxacin in comprehensive treatment of acute inflammatory diseases of the uterus and uterine appendages].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents | 1996 |
Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Cesarean Section; Ciprofloxacin; Endometritis | 1991 |
2 other studies available for ofloxacin and Endomyometritis
| Article | Year |
|---|---|
Therapeutic effects of a new quinolone, DU-6859a, on polymicrobial infections in a newly designed model of rat uterine endometritis.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Disease Models, Animal; Drug Therapy, Combinat | 1998 |
[Levofloxacin in obstetrics and gynecology].
Topics: Adult; Drug Evaluation; Endometritis; Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pelvic I | 1992 |